Newly published research further validates GlucoModicum’s path to high-precision, non-invasive glucose monitor

• The study explains the mechanism behind up to 100× sensitivity amplification in glucose sensors
• The article was published in Biosensors and Bioelectronics, the leading peer-reviewed journal in the field

 

GlucoModicum has published a peer-reviewed article in Biosensors and Bioelectronics presenting key insights into the development of ultrasensitive electrochemical glucose biosensors. Read the full article here.

The research reflects GlucoModicum’s multi-year work in sensor engineering and system-level design. This work forms the basis of GlucoModicum’s product development, including Sofio, the Company’s needle-free glucose monitor based on magnetohydrodynamics.

The work demonstrates how precise control of sensing mechanisms enables consistent, interpretable signals, a requirement for accurate glucose monitoring in real-world settings. This technical foundation supports scalable manufacturing and efficient product refinement as Sofio advances toward market readiness.

Alejandro García Pérez, Chief Technology Officer at GlucoModicum, said: “This publication demonstrates our ability to translate complex physics and electrochemistry into a practical glucose monitoring solution. The principles outlined are directly embedded in Sofio’s development.”